bioAffinity Technologies Inc (BIAF)

[Clean]

Correct me if I'm wrong but I see nothing in any prospectus keeping pre-ipo shareholders from selling SOME of their non-restricted securities. Also some of their restricted holdings will soon be vested and able to be exercised.

Per the investment prospectus, not all of the 6 million previously issued shares are restricted. Some of the stock options are "currently exercisable or exercisable within 60 days"

the last IPO Prospectus after certification states:

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. In computing the number of shares beneficially owned by a person or entity and the percentage ownership of that person or entity in the table below, all shares subject to options and warrants were deemed outstanding if such securities are currently exercisable, or would vest based on service-based vesting conditions within 60 days of August 17, 2022. These shares were not deemed outstanding, however, for the purpose of computing the percentage ownership of any other person or entity.

https://sec.report/Document/0001493152-22-021392/

I mean I could be reading this wrong, but this would lead to me to expect to see more public market dilution adding to the float around October 16th-17th??? The number of OS shown by brokers is already incorrect.

From what I am reading I believe Dilution Tracker to be correct and the OS is now around 8.38 million shares, with insiders owning probably somewhere around 3 million of it.